List of Tables
Table 1. Global Drugs for Ophthalmology Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Drugs for Ophthalmology Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Drugs for Ophthalmology Production Capacity (K Units) by Manufacturers in 2024
Table 4. Global Drugs for Ophthalmology Production by Manufacturers (2020-2025) & (K Units)
Table 5. Global Drugs for Ophthalmology Production Market Share by Manufacturers (2020-2025)
Table 6. Global Drugs for Ophthalmology Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Drugs for Ophthalmology Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Drugs for Ophthalmology, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Drugs for Ophthalmology as of 2024)
Table 10. Global Market Drugs for Ophthalmology Average Price by Manufacturers (USD/Unit) & (2020-2025)
Table 11. Global Key Manufacturers of Drugs for Ophthalmology, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Drugs for Ophthalmology, Product Offered and Application
Table 13. Global Key Manufacturers of Drugs for Ophthalmology, Date of Enter into This Industry
Table 14. Global Drugs for Ophthalmology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Drugs for Ophthalmology Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Drugs for Ophthalmology Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Drugs for Ophthalmology Production Value Market Share by Region (2020-2025)
Table 19. Global Drugs for Ophthalmology Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Drugs for Ophthalmology Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Drugs for Ophthalmology Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Drugs for Ophthalmology Production (K Units) by Region (2020-2025)
Table 23. Global Drugs for Ophthalmology Production Market Share by Region (2020-2025)
Table 24. Global Drugs for Ophthalmology Production (K Units) Forecast by Region (2026-2031)
Table 25. Global Drugs for Ophthalmology Production Market Share Forecast by Region (2026-2031)
Table 26. Global Drugs for Ophthalmology Market Average Price (USD/Unit) by Region (2020-2025)
Table 27. Global Drugs for Ophthalmology Market Average Price (USD/Unit) by Region (2026-2031)
Table 28. Global Drugs for Ophthalmology Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)
Table 29. Global Drugs for Ophthalmology Consumption by Region (2020-2025) & (K Units)
Table 30. Global Drugs for Ophthalmology Consumption Market Share by Region (2020-2025)
Table 31. Global Drugs for Ophthalmology Forecasted Consumption by Region (2026-2031) & (K Units)
Table 32. Global Drugs for Ophthalmology Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Drugs for Ophthalmology Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 34. North America Drugs for Ophthalmology Consumption by Country (2020-2025) & (K Units)
Table 35. North America Drugs for Ophthalmology Consumption by Country (2026-2031) & (K Units)
Table 36. Europe Drugs for Ophthalmology Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 37. Europe Drugs for Ophthalmology Consumption by Country (2020-2025) & (K Units)
Table 38. Europe Drugs for Ophthalmology Consumption by Country (2026-2031) & (K Units)
Table 39. Asia Pacific Drugs for Ophthalmology Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)
Table 40. Asia Pacific Drugs for Ophthalmology Consumption by Region (2020-2025) & (K Units)
Table 41. Asia Pacific Drugs for Ophthalmology Consumption by Region (2026-2031) & (K Units)
Table 42. Latin America, Middle East & Africa Drugs for Ophthalmology Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 43. Latin America, Middle East & Africa Drugs for Ophthalmology Consumption by Country (2020-2025) & (K Units)
Table 44. Latin America, Middle East & Africa Drugs for Ophthalmology Consumption by Country (2026-2031) & (K Units)
Table 45. Global Drugs for Ophthalmology Production (K Units) by Type (2020-2025)
Table 46. Global Drugs for Ophthalmology Production (K Units) by Type (2026-2031)
Table 47. Global Drugs for Ophthalmology Production Market Share by Type (2020-2025)
Table 48. Global Drugs for Ophthalmology Production Market Share by Type (2026-2031)
Table 49. Global Drugs for Ophthalmology Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Drugs for Ophthalmology Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Drugs for Ophthalmology Production Value Market Share by Type (2020-2025)
Table 52. Global Drugs for Ophthalmology Production Value Market Share by Type (2026-2031)
Table 53. Global Drugs for Ophthalmology Price (USD/Unit) by Type (2020-2025)
Table 54. Global Drugs for Ophthalmology Price (USD/Unit) by Type (2026-2031)
Table 55. Global Drugs for Ophthalmology Production (K Units) by Application (2020-2025)
Table 56. Global Drugs for Ophthalmology Production (K Units) by Application (2026-2031)
Table 57. Global Drugs for Ophthalmology Production Market Share by Application (2020-2025)
Table 58. Global Drugs for Ophthalmology Production Market Share by Application (2026-2031)
Table 59. Global Drugs for Ophthalmology Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Drugs for Ophthalmology Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Drugs for Ophthalmology Production Value Market Share by Application (2020-2025)
Table 62. Global Drugs for Ophthalmology Production Value Market Share by Application (2026-2031)
Table 63. Global Drugs for Ophthalmology Price (USD/Unit) by Application (2020-2025)
Table 64. Global Drugs for Ophthalmology Price (USD/Unit) by Application (2026-2031)
Table 65. AbbVie Drugs for Ophthalmology Company Information
Table 66. AbbVie Drugs for Ophthalmology Specification and Application
Table 67. AbbVie Drugs for Ophthalmology Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 68. AbbVie Main Business and Markets Served
Table 69. AbbVie Recent Developments/Updates
Table 70. Aerie Pharmaceuticals Drugs for Ophthalmology Company Information
Table 71. Aerie Pharmaceuticals Drugs for Ophthalmology Specification and Application
Table 72. Aerie Pharmaceuticals Drugs for Ophthalmology Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Aerie Pharmaceuticals Main Business and Markets Served
Table 74. Aerie Pharmaceuticals Recent Developments/Updates
Table 75. Pfizer Drugs for Ophthalmology Company Information
Table 76. Pfizer Drugs for Ophthalmology Specification and Application
Table 77. Pfizer Drugs for Ophthalmology Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Main Business and Markets Served
Table 79. Pfizer Recent Developments/Updates
Table 80. Valeant Drugs for Ophthalmology Company Information
Table 81. Valeant Drugs for Ophthalmology Specification and Application
Table 82. Valeant Drugs for Ophthalmology Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Valeant Main Business and Markets Served
Table 84. Valeant Recent Developments/Updates
Table 85. Bayer Drugs for Ophthalmology Company Information
Table 86. Bayer Drugs for Ophthalmology Specification and Application
Table 87. Bayer Drugs for Ophthalmology Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Bayer Main Business and Markets Served
Table 89. Bayer Recent Developments/Updates
Table 90. Genentech Drugs for Ophthalmology Company Information
Table 91. Genentech Drugs for Ophthalmology Specification and Application
Table 92. Genentech Drugs for Ophthalmology Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Genentech Main Business and Markets Served
Table 94. Genentech Recent Developments/Updates
Table 95. Novartis Drugs for Ophthalmology Company Information
Table 96. Novartis Drugs for Ophthalmology Specification and Application
Table 97. Novartis Drugs for Ophthalmology Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Novartis Main Business and Markets Served
Table 99. Novartis Recent Developments/Updates
Table 100. Regeneron Drugs for Ophthalmology Company Information
Table 101. Regeneron Drugs for Ophthalmology Specification and Application
Table 102. Regeneron Drugs for Ophthalmology Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Regeneron Main Business and Markets Served
Table 104. Regeneron Recent Developments/Updates
Table 105. Takeda Drugs for Ophthalmology Company Information
Table 106. Takeda Drugs for Ophthalmology Specification and Application
Table 107. Takeda Drugs for Ophthalmology Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Takeda Main Business and Markets Served
Table 109. Takeda Recent Developments/Updates
Table 110. Santen Pharmaceutical Drugs for Ophthalmology Company Information
Table 111. Santen Pharmaceutical Drugs for Ophthalmology Specification and Application
Table 112. Santen Pharmaceutical Drugs for Ophthalmology Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Santen Pharmaceutical Main Business and Markets Served
Table 114. Santen Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Drugs for Ophthalmology Distributors List
Table 118. Drugs for Ophthalmology Customers List
Table 119. Drugs for Ophthalmology Market Trends
Table 120. Drugs for Ophthalmology Market Drivers
Table 121. Drugs for Ophthalmology Market Challenges
Table 122. Drugs for Ophthalmology Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drugs for Ophthalmology
Figure 2. Global Drugs for Ophthalmology Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Drugs for Ophthalmology Market Share by Type: 2024 VS 2031
Figure 4. Gels Product Picture
Figure 5. Eye Solutions Product Picture
Figure 6. Capsules & Tablets Product Picture
Figure 7. Eye Drops Product Picture
Figure 8. Ointments Product Picture
Figure 9. Global Drugs for Ophthalmology Market Value by Application, (US$ Million) & (2020-2031)
Figure 10. Global Drugs for Ophthalmology Market Share by Application: 2024 VS 2031
Figure 11. Hospital
Figure 12. Retail Pharmacy
Figure 13. Global Drugs for Ophthalmology Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Drugs for Ophthalmology Production Value (US$ Million) & (2020-2031)
Figure 15. Global Drugs for Ophthalmology Production Capacity (K Units) & (2020-2031)
Figure 16. Global Drugs for Ophthalmology Production (K Units) & (2020-2031)
Figure 17. Global Drugs for Ophthalmology Average Price (USD/Unit) & (2020-2031)
Figure 18. Drugs for Ophthalmology Report Years Considered
Figure 19. Drugs for Ophthalmology Production Share by Manufacturers in 2024
Figure 20. Global Drugs for Ophthalmology Production Value Share by Manufacturers (2024)
Figure 21. Drugs for Ophthalmology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. The Global 5 and 10 Largest Players: Market Share by Drugs for Ophthalmology Revenue in 2024
Figure 23. Global Drugs for Ophthalmology Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 24. Global Drugs for Ophthalmology Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 25. Global Drugs for Ophthalmology Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)
Figure 26. Global Drugs for Ophthalmology Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 27. North America Drugs for Ophthalmology Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Europe Drugs for Ophthalmology Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. China Drugs for Ophthalmology Production Value (US$ Million) Growth Rate (2020-2031)
Figure 30. Japan Drugs for Ophthalmology Production Value (US$ Million) Growth Rate (2020-2031)
Figure 31. Global Drugs for Ophthalmology Consumption by Region: 2020 VS 2024 VS 2031 (K Units)
Figure 32. Global Drugs for Ophthalmology Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 33. North America Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 34. North America Drugs for Ophthalmology Consumption Market Share by Country (2020-2031)
Figure 35. U.S. Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 36. Canada Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 37. Europe Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 38. Europe Drugs for Ophthalmology Consumption Market Share by Country (2020-2031)
Figure 39. Germany Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 40. France Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 41. U.K. Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 42. Italy Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 43. Russia Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 44. Asia Pacific Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 45. Asia Pacific Drugs for Ophthalmology Consumption Market Share by Region (2020-2031)
Figure 46. China Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 47. Japan Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 48. South Korea Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 49. China Taiwan Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 50. Southeast Asia Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 51. India Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 52. Latin America, Middle East & Africa Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 53. Latin America, Middle East & Africa Drugs for Ophthalmology Consumption Market Share by Country (2020-2031)
Figure 54. Mexico Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 55. Brazil Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 56. Turkey Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 57. GCC Countries Drugs for Ophthalmology Consumption and Growth Rate (2020-2031) & (K Units)
Figure 58. Global Production Market Share of Drugs for Ophthalmology by Type (2020-2031)
Figure 59. Global Production Value Market Share of Drugs for Ophthalmology by Type (2020-2031)
Figure 60. Global Drugs for Ophthalmology Price (USD/Unit) by Type (2020-2031)
Figure 61. Global Production Market Share of Drugs for Ophthalmology by Application (2020-2031)
Figure 62. Global Production Value Market Share of Drugs for Ophthalmology by Application (2020-2031)
Figure 63. Global Drugs for Ophthalmology Price (USD/Unit) by Application (2020-2031)
Figure 64. Drugs for Ophthalmology Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
